pr-957 has been researched along with Chronic-Disease* in 1 studies
1 other study(ies) available for pr-957 and Chronic-Disease
Article | Year |
---|---|
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
Chronic antibody-mediated rejection is the major cause of fading allograft function and loss after renal transplantation. Currently, pharmacological agents for the suppression of chronic antibody-mediated rejection are lacking. Non-selective proteasome inhibitors suppress antibody-mediated allograft rejection. However, extensive adverse side effects of these inhibitors severely limit their application. In contrast, immunoproteasome inhibition is effective in preclinical models of autoimmune diseases and was applied over weeks without obvious adverse side effects. ONX 0914, an immunoproteasome subunit LMP7 (β5i)-selective inhibitor, impeded the chronic rejection of kidneys transplanted from Fischer to allogeneic Lewis rats. ONX 0914 inhibited immunoproteasome induction both in immune organs and renal allografts. Selective immunoproteasome inhibition reduced the numbers of B and plasma cells, and suppressed donor-specific alloantibody production. The infiltration of T cells, B cells and macrophages as well as interferon-γ, interleukin-17, IgG and complement deposition were reduced in renal allografts of ONX 0914-treated recipients. Chronic nephropathy was ameliorated and renal allograft function preserved, enabling long-term survival of recipients. Thus, our studies define a critical role of the immunoproteasome in chronic kidney allograft rejection and suggest immunoproteasome inhibition as a promising therapeutic approach to suppress chronic antibody-mediated rejection. Topics: Allografts; Animals; Chronic Disease; Disease Models, Animal; Graft Rejection; Graft Survival; Immunosuppressive Agents; Isoantibodies; Kidney; Kidney Transplantation; Male; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats, Inbred F344; Rats, Inbred Lew; Time Factors | 2018 |